Pharmathen Overview

  • Year Founded
  • 1969

Year Founded

  • Status
  • Private

  • Employees
  • 1,300

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 9

  • Investments
  • 1

Pharmathen General Information

Description

Developer of generic drugs and formulas intended to support improved patient compliance. The company operates as a research-centered, pharmaceutical company that manufactures products like sublingual tablets, hard capsules, eye drops, and ophthalmic services, with new technology platforms and provides optimized pharmaceutical products to patients.

Contact Information

Website
www.pharmathen.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 9, Van Heuven Goedhartlaan
  • 1181 LE Amstelveen
  • Netherlands
+31 020
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Corporate Office
  • 9, Van Heuven Goedhartlaan
  • 1181 LE Amstelveen
  • Netherlands
+31 020

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmathen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmathen‘s full profile, request access.

Request a free trial

Pharmathen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of generic drugs and formulas intended to support improved patient compliance. The company operates as a resea
Pharmaceuticals
Amstelveen, Netherlands
1,300 As of 2023

Pallini, Greece
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmathen Competitors (27)

One of Pharmathen’s 27 competitors is Alvion Pharmaceuticals, a Corporation company based in Pallini, Greece.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alvion Pharmaceuticals Corporation Pallini, Greece
Cipla Corporation Mumbai, India
Glenmark Pharmaceuticals Corporation Mumbai, India
Lannett Company Corporation Trevose, PA
Novartis Corporation Basel, Switzerland
You’re viewing 5 of 27 competitors. Get the full list »

Pharmathen Patents

  • 337

    Total Documents Applications and Grants

  • Total Patents Families

  • 197

    Granted

  • 44

    Pending

  • Expiring in next 12 mo

Pharmathen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4529921-A1 Sustained release microparticles and process for the preparation thereof Pending 26-Sep-2023
GB-2613656-A Sustained release injectable pharmaceutical formulation of levothyroxine and process for preparation thereof Pending 13-Dec-2021
GB-2612779-A Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use Pending 10-Nov-2021
AU-2022360328-A1 Sustained release injectable pharmaceutical formulation of levothyroxine and process for preparation thereof Pending 06-Oct-2021
EP-4412594-A1 Sustained release injectable pharmaceutical formulation of levothyroxine and process for preparation thereof Pending 06-Oct-2021 A61K9/0024
To view Pharmathen’s complete patent history, request access »

Pharmathen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmathen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmathen‘s full profile, request access.

Request a free trial

Pharmathen Investments (1)

Pharmathen’s most recent deal was a Buyout/LBO with Chemical & Biopharmaceutical Laboratories Patras for . The deal was made on 06-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Chemical & Biopharmaceutical Laboratories Patras 06-Nov-2023 Buyout/LBO Pharmaceuticals
To view Pharmathen’s complete investments history, request access »

Pharmathen Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Pharmathen Global Amstelveen, Netherlands 2016
Chemical & Biopharmaceutical Laboratories Patras Patras, Greece 1990

Pharmathen FAQs

  • When was Pharmathen founded?

    Pharmathen was founded in 1969.

  • Where is Pharmathen headquartered?

    Pharmathen is headquartered in Amstelveen, Netherlands.

  • What is the size of Pharmathen?

    Pharmathen has 1,300 total employees.

  • What industry is Pharmathen in?

    Pharmathen’s primary industry is Pharmaceuticals.

  • Is Pharmathen a private or public company?

    Pharmathen is a Private company.

  • What is Pharmathen’s current revenue?

    The current revenue for Pharmathen is .

  • How much funding has Pharmathen raised over time?

    Pharmathen has raised $31.2M.

  • Who are Pharmathen’s investors?

    Partners Group has invested in Pharmathen.

  • Who are Pharmathen’s competitors?

    Alvion Pharmaceuticals, Cipla, Glenmark Pharmaceuticals, Lannett Company, and Novartis are some of the 27 competitors of Pharmathen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »